ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,205.20
0.09%
S&P ASX All Technology
3,465.60
0.32%
Brent Oil
75.605
1.33%
US Dollar vs AUD
1.46013
0.55%
Bitcoin
60,263.86
-0.59%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Galmed Pharmaceuticals Ltd (GLMD) Share Price

Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd (GLMD)

NASDAQ
5.04
-0.78
(-13.40%)
Closed 03 October 6:00AM
Delayed by 15 minutes
5.20
0.16
( 3.17% )
Pre Market: 11:09PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
5.20
Bid
5.06
Offer
5.20
Volume
6,291
0.00 Day's Range 0.00
2.73 52 Week Range 23.80
Market Cap
3.347M
Previous Close
5.04
Open
-
Last Trade
25
@
5.2
Last Trade Time
23:22:20
Financial Volume
-
VWAP
-
Average Volume (3m)
3,083,014
Shares Outstanding
643,690
Dividend Yield
-
PE Ratio
-0.47
Earnings Per Share (EPS)
-10.74
Revenue
-
Net Profit
-6.91M

About Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.galmedpharma.com
Headquarters
Tel Aviv, Center, Isr
Founded
-
Galmed Pharmaceuticals Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLMD. The last closing price for Galmed Pharmaceuticals was US$5.04. Over the last year, Galmed Pharmaceuticals shares have traded in a share price range of US$ 2.73 to US$ 23.80.

Galmed Pharmaceuticals currently has 643,690 shares in issue. The market capitalisation of Galmed Pharmaceuticals is US$3.24 million. Galmed Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.47.

Ask ADVFN Intelligence (AI)

GLMD Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

25 September 2024
Edgar (US Regulatory)

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology PR Newswire TEL AVIV, Israel, Sept. 25, 2024 The paper re-iterates the significant anti-fibrotic effect of Aramchol...

25 September 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

21 September 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

21 September 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

21 September 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

19 September 2024
Edgar (US Regulatory)

Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases

Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases PR Newswire TEL AVIV, Israel, Sept. 19, 2024 Aramchol is the most clinically advanced, first-in-class...

19 September 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 September 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

10 September 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2-27.77777777787.27.764.912302996.54317039CS
42.3481.81818181822.8623.82.822791160312.38967675CS
121.3635.41666666673.8423.82.73308301411.39343671CS
261.2431.31313131313.9623.82.73149547011.0978591CS
52-1.1948-18.68393069376.394823.82.7383416210.46020617CS
156-482.6-98.9339893399487.8563.42.7337491941.96301997CS
260-704-99.2667794698709.21328.42.73293900204.60741328CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 10.74
(0.00%)
157.54k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 63.55
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.96
(0.00%)
1
AACGATA Creativity Global
US$ 0.8955
(0.00%)
583
AALAmerican Airlines Group Inc
US$ 10.74
(0.00%)
157.54k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 63.55
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.96
(0.00%)
1
AACGATA Creativity Global
US$ 0.8955
(0.00%)
583
ELABElevai Labs Inc
US$ 0.0852
(0.00%)
163.33M
PEGYPineapple Energy Inc
US$ 0.1149
(0.00%)
97.64M
MLGOMicroAlgo Inc
US$ 0.31
(0.00%)
40.07M
CDTConduit Pharmaceuticals Inc
US$ 0.095
(0.00%)
26.8M
XPONExpion360 Inc
US$ 0.0466
(0.00%)
10.25M

GLMD Discussion

View Posts
TheFinalCD TheFinalCD 2 weeks ago
HALTED UP
👍️ 1
Surfacetite Surfacetite 2 weeks ago
Pump PR or break new highs?
👍️0
glenn1919 glenn1919 2 weeks ago
GLMD...........................https://stockcharts.com/h-sc/ui?s=GLMD&p=W&b=5&g=0&id=p86431144783
👍️0
knrorrel knrorrel 2 weeks ago
GLMD 🔥🔥🔥
👍️0
Awl416 Awl416 2 weeks ago
Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases
👍️0
Awl416 Awl416 2 weeks ago
There are t1 t2 t3 t12 halts PM AH but NO “volatility” pre or after
👍️0
tw0122 tw0122 2 weeks ago
Always another low floater being pumped then dumped $14s now.
👍️0
knrorrel knrorrel 2 weeks ago
Is it possible that there is never a "halt in trading" after the market closes and also before the market opens tomorrow? And then it would be best to always buy shares before the market closes and sell them shortly after the market opens, then it can never stop. - Have I understood that correctly?

I don't buy because I don't have any money at the moment..... but I get annoyed when I see such stocks rising and I can't play along

lol

👍️0
tw0122 tw0122 2 weeks ago
Little bit support at $15 + 300% then free fall
👍️0
tw0122 tw0122 2 weeks ago
Nice end of day $20- $23
👍️0
glenn1919 glenn1919 2 weeks ago
GLMD...................................https://stockcharts.com/h-sc/ui?s=GLMD&p=W&b=5&g=0&id=p86431144783
👍️0
knrorrel knrorrel 2 weeks ago
$GLMD Will this be the next 1000 percent runner ??? 🔥🔥🔥
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
ISPC NEXT
👍️0
PirateLeviathan8 PirateLeviathan8 2 weeks ago
Remember to find the exit, because when they turn off their machine, the trapdoor opens and then it will most likely go into free fall.....
Just a guess
👍️0
PirateLeviathan8 PirateLeviathan8 2 weeks ago
they have now turned over the entire shares 129x

This is wash trading at its best
👍️0
it_happens it_happens 2 weeks ago
It looks like it's going to go over +500%. Haven't seen that in a while.
👍️0
Triple nickle Triple nickle 2 weeks ago
lol need a push
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
12 GRAND LEFT ON THE TABLE...I'M OFF TO THE NEAREST BRIDGE
👍️0
Awl416 Awl416 2 weeks ago
Hold on to that rug beneath ya
👍️0
Surfacetite Surfacetite 2 weeks ago
So if no offering, this might fly after hrs
👍️0
Awl416 Awl416 2 weeks ago
Dopes
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
LEFT 5 GRAND ON THE TABLE...WHERE IS THE CLOSEST BRIDGE
👍️0
Surfacetite Surfacetite 2 weeks ago
Sold too soon, ugh
👍️0
Awl416 Awl416 2 weeks ago
Did you see that too funny
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RIGHT HERE...ITS ALL THERE...USE YOUR BRAIN
👍️0
Rattlershehe Rattlershehe 2 weeks ago
Where did you call it?
👍️0
Awl416 Awl416 2 weeks ago
Watching l2 is entertaining as F
👍️0
Awl416 Awl416 2 weeks ago
That drop 2 dollar was hilarious
👍️0
Awl416 Awl416 2 weeks ago
Lol
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
CALLED THIS PLAY AT 3.60 WATCH AND LEARN
👍️0
PirateLeviathan8 PirateLeviathan8 2 weeks ago
I'm out at $8.46 and forget about it now

wash trading
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
LEAVING A TONNE ON THE TABLE...WOW
👍️0
Surfacetite Surfacetite 2 weeks ago
Got it.
👍️0
QaB2i QaB2i 2 weeks ago
Absolutely not. Pick your exit
👍️0
Surfacetite Surfacetite 2 weeks ago
Any chance this rise is sustainable?
👍️0
trader59 trader59 2 weeks ago
Computer generated wash trading going on, brazen manipulation of the PPS intended to dump stock onto new bagholders. The O/S has been turned over 50-60 times already. Don't get trapped with grossly overpriced stock.
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
MOTHER TUCKER
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
GLMD BEAST AND OUT
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
GLMD...HERE COMES 7 BUCKS
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
GLMD..MONSTER
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
GLMD THERE SHE GOES...POST SPLIT BIOS EXPLODING
👍️0
tw0122 tw0122 2 weeks ago
Pump me up 6.73 +73%
👍️0
TrendTrade2016 TrendTrade2016 4 weeks ago
GLMD...THERE IT GOES
👍️0
TrendTrade2016 TrendTrade2016 4 weeks ago
GLMD POST SPLIT READY TO TURN UP
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
GLMD POST SPLIT BEASTING
👍️0
Termite7 Termite7 4 months ago
Fiendish chart!!!
👍️0
Awl416 Awl416 7 months ago
Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
👍️0
Monksdream Monksdream 11 months ago
GLMD new 52=week low
👍️0
Monksdream Monksdream 12 months ago
GLMD new 52 week low
👍️0
Monksdream Monksdream 1 year ago
GLMD new 52 week low
👍️0

Your Recent History

NASDAQ
GLMD
Galmed Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved